In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nicotine patch brief accidental exposure led to "few if any" symptoms in children -- study.

This article was originally published in The Tan Sheet

Executive Summary

NICOTINE PATCH BRIEF EXPOSURE IN CHILDREN LED TO "FEW IF ANY" SYMPTOMS in a two-year postmarketing surveillance study of accidental exposures reported to 34 U.S. poison control centers, researchers Alan Woolf, MD, Harvard Medical School, et al. conclude. "In this series of pediatric patients, unintentional and brief (20 minutes or less) exposures to used TNPs [transdermal nicotine patches] resulted in few if any medical symptoms," they report. Published in the May issue of Pediatrics, the study was funded with a grant from ProStep marketer Lederle Labs to the American Association of Poison Control Centers.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel